Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to Azelio's Capital Markets Day 22 September 2022

Azelio is pleased to invite you to a digital Capital Markets Day on Thursday 22 September at 13:00-16:00.   During the Capital Markets Day, presentations will include the status of Azelio's product for energy storage, the TES.POD, Azelio's view of the market, needs, applications and market conditions, strategies and plans going forward.Presentations are held by, among others, Jonas Wallmander, CEO, and parts of the company management. The Capital Markets Day will be held entirely digitally and live-streamed.   More detailed information about the Capital Markets Day and how to

Swedbank has responded to the Swedish Pensions Agency

Swedbank has today responded to the Swedish Pensions Agency’s claim from July 1, 2022. Swedbank disputes the claim.The Swedish Pensions Agency’s claim for SEK 4 billion refers to 2012-2015 when Swedbank acted as a custodian bank for the fund Optimus High Yield. An assignment that ended almost ten years ago. A custodian bank does not have, and has never had, the type of control and supervisory duties that the Swedish Pensions Agency’s claim is founded upon. “The Swedish Pensions Agency lacks necessary legal support for its claim,” says Jens Henriksson, President and CEO of Swedbank.

Valmet invests in press felt production in Finland

Valmet Oyj’s press release August 18, 2022 at 11:00 a.m. EESTValmet further develops its press felt production facilities in Tampere, Finland by investing in new press felt machinery and equipment. The investment includes a new pre-needling line and a new needling line. The amount of the investment is around EUR 18 million. “We target to operate the most modern, efficient and sustainable press felt production unit in the industry. We serve our customers in the board and paper as well as pulp and tissue industries with press felts that respond to the highest quality and performance

Aquaporin will host webcast on August 25 to present first half 2022 results

Copenhagen, Denmark, August 18, 2022 –Aquaporin A/S (AQP.CO) (“Aquaporin” or the “Company”), an innovative water technology company dedicated to natural water treatment, today announced that the Company will be hosting a webcast during which the Chief Executive Officer, Matt Boczkowski, and Chief Financial Officer, Klaus Juhl Wulff, will present the results for the first half of 2022 on August 25 at 3.00 PM CET. The presentation will be followed by a Q&A session. The webcast will be conducted in English. Sign-up for the webcast via this link:https://events.q4inc.com/attendee/123834365

Eficode racks up high growth driven by international demand

The 71,3% revenue growth was fueled by the Eficode ROOT managed DevOps platform, international expansion, and cross-sales.Helsinki, Finland, 18 August 2022 -- Eficode’s revenue grew by 71,3% in its last fiscal year, up from 46,4 million to 79,5 million euros. The revenue has now more than tripled in three years, and there are several contributing factors. Companies want development tools and processes managed by experts Working with expert companies to build and maintain DevOps toolchains is becoming a prevalent strategy. Eficode is well positioned to meet this demand, as proven by

Azelio commissions system in Haneberg

Azelio has taken an energy storage system into operation at Haneberg Farm in Sweden. The system is powered by solar panels and utilizes both electricity and heat generated by the system to dry grain.   "This is an important milestone for Azelio since it is the first time a project also uses the heat generated by Azelio's energy storage system. We see many applications for the heat, both in the agricultural sector and in other areas. Haneberg will serve as springboard for continued development of this part of the system," says CEO Jonas Wallmander.   The system is part of a

Arctic Bioscience – Invitation to presentation of half year 2022 results

Arctic Bioscience will publish its financial results for the half year 2022 on Thursday 25 August, at 08:00 CET.The same day at 10:00 CET, the Company will host a webcast to present the results. Following the presentation, it will be opened for questions from the audience. Webcast details: Date: Thursday 25 August 2022 Time: 10:00 CET Format: Webcast and Q&A Language: English Link: https://channel.royalcast.com/landingpage/hegnarmedia/20220825_11/ Participants will be required to register to view the webcast and participate in the Q&A.

WindowMaster releases half-year report 2022: Historically high order intake and revenue, and strong rebound in profitability in Q2

Company Announcement No. 028-2022 – Inside informationVedbaek, 18th August 2022 Financial Highlights H1 2022 - Historically high order intake and revenue, and strong rebound in profitability in Q2 · Order intake increased 25% to DKK 143.7m in H1 2022 (H1 2021: DKK 114.6m) · Revenue increased 10% to DKK 117.8m in H1 2022 (H1 2021: DKK 107.3m) · EBITDA increased 18% to DKK 6.4 (H1 2021: DKK 5.5m) corresponding to an EBITDA margin of 5.5% (H1 2021: 5.1%) · The outlook for 2022 is maintained. Revenue is still expected to be in the range of DKK 220-235m and EBITDA between DKK

Norse Atlantic Airways celebrates inaugural flights from Berlin and announces new Berlin to Fort Lauderdale route

This week Norse Atlantic Airways celebrated the inaugural flights from Berlin to New York JFK and from Berlin to Los Angeles marking a new era for customers seeking affordable transatlantic travel between Germany and the US.Additionally, Norse Atlantic announced a new route connecting Berlin to Fort Lauderdale, operating three times a week, this new route will commence on 7[th] December with tickets available to purchase now from €228 one way. “We are very pleased to now be able to welcome customers from across Germany on board our state-of-the-art Boeing 787 Dreamliners to New York and

Semcon wins framework agreement with Getinge

Semcon has signed a new three-year framework agreement with Getinge regarding technical consulting services within life science, covering both product and production development.With more than 35 years of experience in life science, Semcon supports customers in developing user-friendly medical devices, quality-assured pharmaceuticals, and efficient digital information solutions. “We look forward to continuing to support Getinge in their important work. This new agreement means great opportunities for us at Semcon, especially in Stockholm and Växjö, but also in Gothenburg and Getinge's

Invitation to presentation of Ranplan’s H1 interim report 2022

Stockholm, Sweden, 18 August 2022 – Ranplan Group AB is pleased to invite media, investors, shareholders and financial analysts to a video conference meeting from its office in the city of Stockholm. On this occasion, CEO Per Lindberg and CSO Jon Ullmark will present the report for the first six months of 2022. Those who want to participate online at this event should notify the company of their interest before 6pm CET on 24 Aug 2022 by sending an e-mail to joyce.wu@ranplanwireless.com (joyce.wu@ranplanwireless.com?subject=2022%20H1%20Interim%20Report%20Invitation). On the morning of 25

The exercise period for warrants of series TO 1 begins today

Today, 18 August 2022, marks the beginning of the exercise period for warrants of series TO 1, that were issued in connection with CS MEDICA A/S’s (“CS MEDICA” or the “Company”) issue of units that took place in September 2021. The exercise period runs until and including 1 September 2022. Upon full exercise of warrants of series TO 1, CS MEDICA will receive approx. DKK 10.8 million before deduction of transaction related costs. An information document and subscription forms are available on the websites of CS MEDICA (www.cs-medica.com), Sedermera Corporate Finance AB (www.sedermera.se) and

TG’s favorite model is renewed

The TG 5.9 has been Finland’s best-selling cabin boat for several years. Now TG boats is launching a new model, TG 6.1, based on the favorite model. The timeless design and the glued windshield make the TG 6.1 modern and stylish. The new TG 6.1 will be shown for the first time at the Floating boat show in Helsinki on August 18-21.The TG 6.1 follows the modern design known from the other TG boats. The boat’s high sides, practically shaped bow and extensive railings make it comfortable and safe to move around on the foredeck for both children and adults. The front rails are attached with

NORDEN initiates share buy-back programme

ANNOUNCEMENT NO. 158 - 18 AUGUST 2022 The Board of Directors has decided to carry out a share buy-back of up to a total of USD 40 million (approximately DKK 290 million). The share buy-back programme is initiated pursuant to the authorisation granted to the Board of Directors, which entitles NORDEN to acquire treasury shares at a nominal value not exceeding 15% of the share capital at the market price applicable at the time of acquisition with a deviation of up to 10%. This authorisation was granted at NORDEN’s general meeting on 24 March 2022.   Purpose The purpose of the share

Interim report Q2, 2022

Second quarter · Net sales amounted to SEK 21.8 (14.1) million · EBITDA* amounted to SEK -0.4 (-1.5) million · EBIT amounted to SEK –16.9 (-21.9) million   · EBT amounted to SEK -20.0 (-23.8) million · Earnings per share before dilutions amounted to -0,05 (-0.08) Significant events during the reporting period · Ampilio signs partnership agreement with Atlas Copco · Google Digitalakademin has chosen to renew its collaboration with Ampilio, subsidiary of SpectrumOne · Johan Holmberg appointed interim CEO of SpectrumOne AB · Observit AB, a subsidiary of

Half year Report January - June 2022

April – June 2022- Net Sales MSEK 124.5 (125.8)- Order intake MSEK 239.7 (46.9)- Operating profit (EBITDA) MSEK 17.7 (13.5)- Operating profit (EBIT) MSEK 7.1 (4.6)- Total Comprehensive income MSEK 27.5 (-1.0)- Earnings per share, before and after dilution (SEK) 0.01 (0.00)- Cash flow from operating activities MSEK 30.8 (38.2) January – June 2022- Net Sales MSEK 237.9 (203.9)- Order intake MSEK 323.2 (108.7)- Operating profit (EBITDA) MSEK 33.3 (8.0)- Operating profit (EBIT) MSEK 12.7 (-9.6)- Total Comprehensive income MSEK 39.8 (-2.0)- Earnings per share, before

Qlife updates vision and websites – Reinforced emphasis on making Egoo Health available for home use

Qlife today presents an updated vision and new websites for corporate and IR communication as well as for the company’s diagnostics self-testing platform Egoo Health. The objective is to emphasize the foundation of Qlife’s purpose to help improve quality of life for every individual and for the future society by making Egoo Health available for home use.Qlife was founded based on the idea that Egoo Health could help people lead a better life by using the diagnostics self-testing platform Egoo Health. Today, the short-term focus is on completing product development and approvals for CRP (

CS MEDICA A/S: CFO Gitte Lund Henriksen buys more shares in the Company

CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the CFO of the Company, Gitte Lund Henriksen, has acquired 2 500 shares in CS MEDICA through several transactions, at an average price of 10,75, amounting to a total value of 27 250 DKK.CFO and board member of CS MEDICA, Gitte Lund Henriksen, has purchased 2 500 shares in the open market at an average price of DKK 10,75 per share, corresponding to a total purchase of 27 250 DKK. The transaction has been disclosed in the Danish financial supervisory register. Following the transaction, Gitte Lund Henriksen owns 4 039 500 CS

ExpreS2ion announces financial results for the second quarter 2022

Hørsholm, Denmark, August 18, 2022 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its second quarter financial results for 2022. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments “During the second quarter of 2022, we continued to deliver strong progress in our key pipeline projects, as well as in the overall company development. We see excellent potential in our ongoing efforts to move ExpreS[2]ion higher up in the value chain by developing our own pipeline projects.

Minesto publishes Half-Year Report 2022

CEO Dr Martin Edlund: “There are immediate opportunities where our small scale systems and competitive LCOE profile make a difference”.Significant events April-June 2022 · In April, Minesto launched a build-out plan for tidal energy arrays in the Faroe Islands. The plan includes four new verified sites with the potential to supply 40 percent of the country's growing electricity consumption, enabling the Faroe Islands to reach their policy goal of 100 percent renewable energy by 2030. Together with the local electricity company SEV, Minesto has presented the plan to a wide range of

Axel Schörling has, in accordance with the plan, started as new CEO in EQL Pharma AB and Martin Kristoffersson is appointed new COO.

Christer Fåhraeus, Founder & CEO, notified the Board in the autumn of 2021 that he intends to transition into a Board position after the Annual General Meeting (“AGM”) in August 2022. At that time, the Board appointed Axel Schörling, Deputy CEO, as new CEO after Fåhraeus´ resignation following the AGM in August 2022. After todays AGM, Schörling has assumed the position as new CEO in EQL. In connection with this, Martin Kristofferson, previously Director Strategic Sourcing, has been appointed new COO.Christer Fåhraeus, new Chairman of the Board, will remain a dedicated and committed main

Lumito publishes Quarterly Report 2, 2022

First half of the year 1 January–30 June 2022 · Net sales amounted to KSEK 0 (0). · Result after taxes amounted to KSEK -13,610 (-13,444). · Basic and diluted earnings per share amounted to SEK -0.09 (-0.15) · Cash flow from operating activities after change in working capital amounted to KSEK -14,636 (-12,883). · Cash and cash equivalents amounted to KSEK 32,275 (18,120) on the balance sheet date. Financial overview of the second quarter, 1 April to 30 June 2022 · Net sales amounted to KSEK 0 (0). · Result after taxes amounted to KSEK -7,180 (-6,619). ·

Interim financial report for the period 1 January – 30 June 2022 and adjusted financial outlook for 2022

Company Announcement 32/2022 First half of 2022 was characterised by historically challenging markets with distressed supply chains and high-cost inflation. Q2 2022 margins were pressured by immediate surcharges from suppliers, while adjustments to sales prices are expected to positively impact margins in H2 2022. Demand for newbuilds have decreased and the lower sales levels are expected to continue. A reorganisation is initiated on 18 August. Outlook for 2022 is adjusted due to lower expected sales for 2022, delayed effect of sales price adjustments and special items in relation to

NORDEN achieves fantastic Q2 result and pays interim dividend to shareholders

ANNOUNCEMENT NO. 157 - 18 AUGUST 2022 For Q2 2022 NORDEN reports a profit of USD 179 million (approx. DKK 1.3 bill.) (Q2 2021: USD 32 million - approx. DKK 233 mill.). Cash flow from operating activities amount to approx. USD 350 mill. (approx. DKK 2.6 bill.).   NORDEN CEO, Jan Rindbo, comments: “Fantastic second quarter result based on a significant shift in market exposure from dry cargo to product tankers. This has enabled NORDEN to capitalise on the exceptional product tanker rates, while also generating value in a weakening dry cargo market from an extensive cargo and cover

There are no items matching the current filter
There are no more items matching the current filter
Back to top